Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silver Nitrate vs Triamcinolone vs Combination for Hypergranulation Tissue in Traumatic Wounds
NCT06681194Phase 3Withdrawn
- Start
- Mar 2025
- Primary completion
- Feb 2026
- Modality
- Transdermal Patches, Orthosteric Ligands, Hydrogel Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of silver nitrate and triamcinolone acetonide in hypergranulation tissue (3 arms). Primary endpoints: Reduction in Hypergranulation Tissue Size, Vancouver Scar Scale and 2 more. Planned start Mar 2025; status: withdrawn.
02
Drugs
silver nitratetriamcinolone acetonide
03
Conditions
hypergranulation tissue
Beyond the preview
Go deeper on NCT06681194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06681194.